Protalix BioTherapeutics
PLX
#7972
Rank
A$0.34 B
Marketcap
$4.35
Share price
-2.28%
Change (1 day)
136.46%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): A$8.24 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are A$53.39 Million. a decrease over its 2023 earnings that were of A$18.33 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 A$8.13 M-55.62%
2023 A$18.33 M-199.05%
2022 -A$18.52 Million-40.38%
2021 -A$31.06 Million-732.31%
2020 A$4.91 M-130.53%
2019 -A$16.09 Million189.85%
2018 -A$5.55 Million-95.29%
2017 -A$0.12 Billion308.12%
2016 -A$28.89 Million-32.37%
2015 -A$42.71 Million10.11%
2014 -A$38.79 Million-7.59%
2013 -A$41.98 Million
2011 -A$48.61 Million-19.39%
2010 -A$60.3 Million20.87%
2009 -A$49.89 Million32.26%
2008 -A$37.72 Million-5.46%
2007 -A$39.9 Million
2004 -A$0.26 Million12.35%
2003 -A$0.23 Million-11.1%
2002 -A$0.26 Million-57.03%
2001 -A$0.61 Million1.03%
2000 -A$0.6 Million-53.22%
1999 -A$1.28 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$44.87 Million-651.30%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.80 B 9,740.87%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.33 B 212,955.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$0.45 Billion-5,506.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel